223 related articles for article (PubMed ID: 7589081)
1. Differential binding of human interleukin-1 (IL-1) receptor antagonist to natural and recombinant soluble and cellular IL-1 type I receptors.
Svenson M; Nedergaard S; Heegaard PM; Whisenand TD; Arend WP; Bendtzen K
Eur J Immunol; 1995 Oct; 25(10):2842-50. PubMed ID: 7589081
[TBL] [Abstract][Full Text] [Related]
2. Binding of IL-1 alpha, IL-1 beta, and IL-1 receptor antagonist by soluble IL-1 receptors and levels of soluble IL-1 receptors in synovial fluids.
Arend WP; Malyak M; Smith MF; Whisenand TD; Slack JL; Sims JE; Giri JG; Dower SK
J Immunol; 1994 Nov; 153(10):4766-74. PubMed ID: 7963543
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory activity of IL-1 receptor antagonist depends on the balance between binding capacity for IL-1 receptor type 1 and IL-1 receptor type II.
Ruggiero P; Bossù P; Macchia G; Del Grosso E; Sabbatini V; Bertini R; Colagrande A; Bizzarri C; Maurizi G; Di Cioccio V; D'Andrea G; Di Giulio A; Frigerio F; Grifantini R; Grandi G; Tagliabue A; Boraschi D
J Immunol; 1997 Apr; 158(8):3881-7. PubMed ID: 9103457
[TBL] [Abstract][Full Text] [Related]
4. Mapping of receptor binding sites on IL-1 beta by reconstruction of IL-1ra-like domains.
Boraschi D; Bossù P; Ruggiero P; Tagliabue A; Bertini R; Macchia G; Gasbarro C; Pellegrini L; Melillo G; Ulisse E; Visconti U; Bizzarri C; Del Grosso E; Mackay AR; Frascotti G; Frigerio F; Grifantini R; Grandi G
J Immunol; 1995 Nov; 155(10):4719-25. PubMed ID: 7594472
[TBL] [Abstract][Full Text] [Related]
5. Specific binding of interleukin 1 (IL-1) beta and IL-1 receptor antagonist (IL-1ra) to human serum. High-affinity binding of IL-1ra to soluble IL-1 receptor type I.
Svenson M; Hansen MB; Heegaard P; Abell K; Bendtzen K
Cytokine; 1993 Sep; 5(5):427-35. PubMed ID: 8142597
[TBL] [Abstract][Full Text] [Related]
6. Detection and modulation of interleukin-1 receptor antagonist messenger ribonucleic acid and immunoreactivity in Graves' orbital fibroblasts.
Mühlberg T; Heberling HJ; Joba W; Schworm HD; Heufelder AE
Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):1018-28. PubMed ID: 9112998
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-1 (IL-1alpha and IL-1beta) and its receptors (IL-1RI, IL-1RII, and IL-1Ra) in prostate carcinoma.
Ricote M; García-Tuñón I; Bethencourt FR; Fraile B; Paniagua R; Royuela M
Cancer; 2004 Apr; 100(7):1388-96. PubMed ID: 15042672
[TBL] [Abstract][Full Text] [Related]
8. Elevated levels of soluble interleukin-1 receptor type II and interleukin-1 receptor antagonist in patients with chronic arthritis: correlations with markers of inflammation and joint destruction.
Jouvenne P; Vannier E; Dinarello CA; Miossec P
Arthritis Rheum; 1998 Jun; 41(6):1083-9. PubMed ID: 9627018
[TBL] [Abstract][Full Text] [Related]
9. Soluble interleukin-1 receptor accessory protein ameliorates collagen-induced arthritis by a different mode of action from that of interleukin-1 receptor antagonist.
Smeets RL; Joosten LA; Arntz OJ; Bennink MB; Takahashi N; Carlsen H; Martin MU; van den Berg WB; van de Loo FA
Arthritis Rheum; 2005 Jul; 52(7):2202-11. PubMed ID: 15986350
[TBL] [Abstract][Full Text] [Related]
10. Mouse IL-1 receptor antagonist isoforms: complementary DNA cloning and protein expression of intracellular isoform and tissue distribution of secreted and intracellular IL-1 receptor antagonist in vivo.
Gabay C; Porter B; Fantuzzi G; Arend WP
J Immunol; 1997 Dec; 159(12):5905-13. PubMed ID: 9550387
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a low molecular weight isoform of IL-1 receptor antagonist.
Malyak M; Guthridge JM; Hance KR; Dower SK; Freed JH; Arend WP
J Immunol; 1998 Aug; 161(4):1997-2003. PubMed ID: 9712072
[TBL] [Abstract][Full Text] [Related]
12. Monotonicity of interleukin-1 receptor-ligand binding with respect to antagonist in the presence of decoy receptor.
Gnacadja G; Shoshitaishvili A; Gresser MJ; Varnum B; Balaban D; Durst M; Vezina C; Li Y
J Theor Biol; 2007 Feb; 244(3):478-88. PubMed ID: 17011587
[TBL] [Abstract][Full Text] [Related]
13. Soluble murine IL-1 receptor type I induces release of constitutive IL-1 alpha.
Netea MG; Kullberg BJ; Boerman OC; Verschueren I; Dinarello CA; Van der Meer JW
J Immunol; 1999 Apr; 162(8):4876-81. PubMed ID: 10202032
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical analysis of interleukin-1 alpha, its type I receptor and antagonist in keratocystic odontogenic tumors.
Suyama Y; Kubota Y; Ninomiya T; Shirasuna K
J Oral Pathol Med; 2008 Oct; 37(9):560-4. PubMed ID: 18624935
[TBL] [Abstract][Full Text] [Related]
15. The type II IL-1 receptor interacts with the IL-1 receptor accessory protein: a novel mechanism of regulation of IL-1 responsiveness.
Lang D; Knop J; Wesche H; Raffetseder U; Kurrle R; Boraschi D; Martin MU
J Immunol; 1998 Dec; 161(12):6871-7. PubMed ID: 9862719
[TBL] [Abstract][Full Text] [Related]
16. The inhibitory activity of human interleukin-1 receptor antagonist is enhanced by type II interleukin-1 soluble receptor and hindered by type I interleukin-1 soluble receptor.
Burger D; Chicheportiche R; Giri JG; Dayer JM
J Clin Invest; 1995 Jul; 96(1):38-41. PubMed ID: 7615809
[TBL] [Abstract][Full Text] [Related]
17. [Effects of IL-1 receptor antagonist on the level of cytokine in the rat corneal grafts and aqueous humor after corneal transplantation].
Zhang WH; Zhai CB; Pan ZQ; Wu YY
Zhonghua Yan Ke Za Zhi; 2003 Oct; 39(10):587-91. PubMed ID: 14766071
[TBL] [Abstract][Full Text] [Related]
18. Soluble type II interleukin 1 (IL-1) receptor binds and blocks processing of IL-1 beta precursor and loses affinity for IL-1 receptor antagonist.
Symons JA; Young PR; Duff GW
Proc Natl Acad Sci U S A; 1995 Feb; 92(5):1714-8. PubMed ID: 7878046
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-1-induced activation of a protein kinase co-precipitating with the type I interleukin-1 receptor in T cells.
Martin M; Böl GF; Eriksson A; Resch K; Brigelius-Flohé R
Eur J Immunol; 1994 Jul; 24(7):1566-71. PubMed ID: 8026518
[TBL] [Abstract][Full Text] [Related]
20. Anion binding and controlled aggregation of human interleukin-1 receptor antagonist.
Raibekas AA; Bures EJ; Siska CC; Kohno T; Latypov RF; Kerwin BA
Biochemistry; 2005 Jul; 44(29):9871-9. PubMed ID: 16026159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
